Liu; Shi-Hui

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liu; Shi-Hui.The latest application filed is for "modified anthrax toxin protective antigen".

Company Profile

1.8.7

Liu; Shi-Hui - Gaithersburg MD
Liu; Shi-Hui - Bethesda MD US
Liu, Shi-Hui - Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified anthrax toxin protective antigen Grant 10,835,593 - Liu , et al. November 17, 2	2020-11-17
Modified Anthrax Toxin Protective Antigen App 20180250376 - Liu; Shi-Hui ; et al.	2018-09-06
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors Grant 9,403,872 - Leppla , et al. August 2, 2	2016-08-02
Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts Of Cell-surface Metalloproteinases Or Plasminogen Activator Receptors App 20140378654 - LEPPLA; Stephen H. ; et al.	2014-12-25
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors Grant 8,791,074 - Leppla , et al. July 29, 2	2014-07-29
Multimeric protein toxins to target cells having multiple identifying characteristics Grant 8,388,933 - Leppla , et al. March 5, 2	2013-03-05
Multimeric Protein Toxins To Target Cells Having Multiple Identifying Characteristics App 20110280908 - Leppla; Stephen H. ; et al.	2011-11-17
Multimeric protein toxins to target cells having multiple identifying characteristics Grant 7,947,289 - Leppla , et al. May 24, 2	2011-05-24
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors App 20090142794 - Leppla; Stephen H. ; et al.	2009-06-04
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors Grant 7,468,352 - Leppla , et al. December 23, 2	2008-12-23
Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells App 20080166375 - Leppla; Stephen H. ; et al.	2008-07-10
Multimeric protein toxins to target cells having multiple identifying characteristics App 20050255083 - Leppla, Stephen H. ; et al.	2005-11-17
Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases App 20050123476 - Bugge, Thomas H. ; et al.	2005-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.